ArticleCancer immunology, immunotherapy : CII2025

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1.

Hirotaka Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.